Organon Czech Republic

Table of Products

AdrovanceProduct information
AerinazeProduct information
AeriusProduct information
ArcoxiaProduct information
AsmanexProduct information
AzomyrProduct information
CerazetteProduct information
DiprosalicProduct information
DiprosoneProduct information
ElocomProduct information
ElonvaProduct information
EzetrolProduct information
FosavanceProduct information
InegyProduct information
LerivonProduct information
LivialProduct information
LixianaProduct information
MarvelonProduct information
MercilonProduct information
NasonexProduct information
NeoclaritynProduct information
NuvaringProduct information
OntruzantProduct information
OrgalutranProduct information
OrgametrilProduct information
PuregonProduct information
SingulairProduct information
SycrestProduct information
VantavoProduct information
ZoletorvProduct information

VPOIS

You have entered a publicly accessible section that contains information on all registered medicines represented by Merck Sharp & Dohme s.r.o. The obligation to establish this “Publicly Available Professional Information Service – VPOIS” follows from Act No. 378/2007 Coll., On Pharmaceuticals, as amended (Section 33 (3) (g) (1)). Up-to-date information on individual products and their availability can be found on the website of the State Institute for Drug Control after selecting a specific product from the list below, respectively by clicking on the highlighted text: Product Information. The patient information leaflet is available in the column labelled PIL. Please also note that the patient information leaflet does not in any way replace the advice of a doctor or pharmacist.

Products that have a stipulated reimbursement from health insurance are color-coded and have a symbol. Products with an active occurrence on the Czech market according to regular reports of distributors’ deliveries in the previous three months (with a one-month interval) are marked with a symbol and are shown in bold.

Information service for the blind and visually impaired is available at +420 233 010 300. If you have any questions about a specific Organon product, please contact us at Organon Czech Republic s.r.o., Národní 135/14, 110 00 Prague 1, Czech Republic or by email at  dpoc.czech@organon.com or phone +420 233 010 300.

You can find up-to-date information on the availability of medicines in the database here.

Contact us banner image

Organon Czech Republic s.r.o.

Národní 135/14, 110 00 Prague 1, Czech Republic

Contact us banner image

Report Adverse Event to PharmDr. Jana Tomovič Čačaná

Please specify:

  • what kind of medication the unintended or unfavourable response affects
  • when you or your patient has experienced an adverse event
  • responding to the drug you think is an adverse event
  • if you are a patient, please contact your doctor who has treated you when the adverse event has occurred, please ask for informed consent to contact your doctor
  • your contact information (name, surname, phone number, email)

You can also report adverse event on the website